Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 30, 2010
Alveolar inflammation in cystic fibrosis
Martina Ulrich, Dieter Worlitzsch, Simona Viglio, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2026
Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS)
Stefan S Bielack, Dimosthenis Andreou, Daniel Baumhoer, et al.
Cancer Medicine
|
September 9, 2025
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS)
Stefan S Bielack, Vanessa Mettmann, Daniel Baumhoer, et al.
Anticancer Research
|
October 28, 2025
Osteosarcoma of the Diaphysis: A Report from the Cooperative Osteosarcoma Study Group (COSS)
Stefan S Bielack, Claudia Blattmann, Leo Kager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
Wilfried Ernst Erich Eberhardt, Christoph Pöttgen, Thomas Christoph Gauler, et al.
International Journal of Cancer
|
August 29, 2024
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)
Christina Schulte, Thomas Gauler, Christoph Pöttgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2026
Ten-year overall survival in resectable stage-III NSCLC - Results of the randomized ESPATUE trial - Long-term survival and competing risk analysis
Wilfried Ernst Erich Eberhardt, Christina Schulte, Christoph Pöttgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
Sigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 30, 2010
Alveolar inflammation in cystic fibrosis
Martina Ulrich, Dieter Worlitzsch, Simona Viglio, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2026
Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS)
Stefan S Bielack, Dimosthenis Andreou, Daniel Baumhoer, et al.
Cancer Medicine
|
September 9, 2025
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS)
Stefan S Bielack, Vanessa Mettmann, Daniel Baumhoer, et al.
Anticancer Research
|
October 28, 2025
Osteosarcoma of the Diaphysis: A Report from the Cooperative Osteosarcoma Study Group (COSS)
Stefan S Bielack, Claudia Blattmann, Leo Kager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
Wilfried Ernst Erich Eberhardt, Christoph Pöttgen, Thomas Christoph Gauler, et al.
International Journal of Cancer
|
August 29, 2024
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)
Christina Schulte, Thomas Gauler, Christoph Pöttgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2026
Ten-year overall survival in resectable stage-III NSCLC - Results of the randomized ESPATUE trial - Long-term survival and competing risk analysis
Wilfried Ernst Erich Eberhardt, Christina Schulte, Christoph Pöttgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
Sigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.
Page
of 8